X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs LUPIN LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH LUPIN LTD STERLING BIOTECH/
LUPIN LTD
 
P/E (TTM) x -1.8 16.3 - View Chart
P/BV x 0.1 3.8 1.9% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 STERLING BIOTECH   LUPIN LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
LUPIN LTD
Mar-16
STERLING BIOTECH/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs112,127 0.5%   
Low Rs31,294 0.3%   
Sales per share (Unadj.) Rs26.8304.1 8.8%  
Earnings per share (Unadj.) Rs-15.050.4 -29.7%  
Cash flow per share (Unadj.) Rs-5.560.7 -9.0%  
Dividends per share (Unadj.) Rs07.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs54.9243.8 22.5%  
Shares outstanding (eoy) m267.87450.58 59.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.35.6 4.6%   
Avg P/E ratio x-0.533.9 -1.4%  
P/CF ratio (eoy) x-1.328.2 -4.5%  
Price / Book Value ratio x0.17.0 1.8%  
Dividend payout %014.9 0.0%   
Avg Mkt Cap Rs m1,862770,740 0.2%   
No. of employees `0001.416.4 8.3%   
Total wages/salary Rs m54721,077 2.6%   
Avg. sales/employee Rs Th5,303.38,379.6 63.3%   
Avg. wages/employee Rs Th403.81,289.0 31.3%   
Avg. net profit/employee Rs Th-2,959.01,388.7 -213.1%   
INCOME DATA
Net Sales Rs m7,181137,016 5.2%  
Other income Rs m431,877 2.3%   
Total revenues Rs m7,223138,893 5.2%   
Gross profit Rs m94737,535 2.5%  
Depreciation Rs m2,5434,635 54.9%   
Interest Rs m4,377446 981.0%   
Profit before tax Rs m-5,93134,330 -17.3%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92411,536 -16.7%   
Profit after tax Rs m-4,00722,707 -17.6%  
Gross profit margin %13.227.4 48.1%  
Effective tax rate %32.433.6 96.6%   
Net profit margin %-55.816.6 -336.7%  
BALANCE SHEET DATA
Current assets Rs m14,33597,790 14.7%   
Current liabilities Rs m49,80953,872 92.5%   
Net working cap to sales %-494.032.1 -1,541.3%  
Current ratio x0.31.8 15.9%  
Inventory Days Days40385 476.3%  
Debtors Days Days171121 140.8%  
Net fixed assets Rs m55,43286,379 64.2%   
Share capital Rs m268901 29.7%   
"Free" reserves Rs m13,935105,735 13.2%   
Net worth Rs m14,701109,844 13.4%   
Long term debt Rs m9,47853,739 17.6%   
Total assets Rs m73,988224,378 33.0%  
Interest coverage x-0.477.9 -0.5%   
Debt to equity ratio x0.60.5 131.8%  
Sales to assets ratio x0.10.6 15.9%   
Return on assets %0.510.3 4.9%  
Return on equity %-27.320.7 -131.8%  
Return on capital %-6.421.2 -30.3%  
Exports to sales %25.949.1 52.8%   
Imports to sales %0.27.4 2.3%   
Exports (fob) Rs m1,86067,244 2.8%   
Imports (cif) Rs m1210,199 0.1%   
Fx inflow Rs m1,86071,405 2.6%   
Fx outflow Rs m2517,807 0.1%   
Net fx Rs m1,83553,598 3.4%   
CASH FLOW
From Operations Rs m1,719-3,690 -46.6%  
From Investments Rs m-3,148-69,434 4.5%  
From Financial Activity Rs m1,42658,126 2.5%  
Net Cashflow Rs m-3-14,998 0.0%  

Share Holding

Indian Promoters % 33.9 46.6 72.7%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 9.9 31.9 31.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 10.1 389.1%  
Shareholders   21,482 98,259 21.9%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DR. DATSONS LABS  STRIDES SHASUN LTD  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 21, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS